Related Experiment Videos
An inhibitor of macrophage chemotaxis produced by neoplasms
Abstract:
The accumulation of macrophages at neoplastic sites may be an important event in immunologically mediated tumor killing. The implantation of syngeneic neoplasms in mice, however, was found to depress the animal's ability to localize macrophages at inflammatory sites. A low-molecular-weight (6,000 to 10,000) factor released by growing neoplasms that inhibits the accumulation of macrophages in vivo and chemotactic responsiveness in vitro was identified. The factor is active in the inhibition of macrophages and is ineffectual at retarding the migration of polymorphonuclear leukocytes. Neoplastic cells may thus abrogate immunosurveillance by releasing products that prevent potentially tumoricidal macrophages from accumulating at sites of developing malignancies.
Insights
Tumors release a factor that prevents macrophages from reaching neoplastic sites, hindering immune responses. This mechanism may allow cancer cells to evade immune surveillance and grow unchecked.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Macrophage accumulation at tumor sites is crucial for immune-mediated tumor destruction.
- Cancer growth can impair the host's immune response, facilitating tumor progression.
Purpose of the Study:
- To investigate how growing neoplasms affect macrophage localization and function.
- To identify factors released by tumors that influence immune cell behavior.
Main Methods:
- Implantation of syngeneic neoplasms in mice.
- Assessing macrophage accumulation at inflammatory sites.
- Identifying and characterizing a low-molecular-weight factor from neoplasms.
Main Results:
- Neoplasm implantation suppressed macrophage localization at inflammatory sites.
- A low-molecular-weight factor (6-10 kDa) was identified, inhibiting macrophage accumulation in vivo and chemotaxis in vitro.
- This factor specifically inhibited macrophages, not polymorphonuclear leukocytes.
Conclusions:
- Neoplastic cells release a factor that impairs macrophage function and accumulation.
- This tumor-derived factor may represent a mechanism for abrogating immunosurveillance.
- By preventing macrophage infiltration, tumors can evade immune attack and promote malignancy.